Loading...
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
Recently, two “fixed triple” single-inhaler combinations of an inhaled corticosteroid (ICS), a long-acting β(2)-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) have become available for patients with COPD. This review presents the clinical evidence that led to the approval of these tr...
Na minha lista:
| Udgivet i: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6296179/ https://ncbi.nlm.nih.gov/pubmed/30587953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S185975 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|